Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human NDP ELISA Kit (AC3133)
Cat.#: ASET-1722
Specifications
Description Human NDP ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human NDP concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.056 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2519 Human Laminin beta 2 ELISA Kit (AC3930) Quantitative inquiry ASET-2243 Human Dopamine Receptor D1 ELISA Kit (AC3654) Quantitative inquiry ASET-1971 Canine Adiponectin ELISA Kit (AC3382) Quantitative inquiry ASET-2209 Mouse TMPRSS2 ELISA Kit (AC3620) Quantitative inquiry ASET-1622 Human ASRGL1 ELISA Kit (AC3033) Quantitative inquiry ASET-1877 Mouse CacyBP ELISA Kit (AC3288) Quantitative inquiry ASET-1679 Human Synaptogyrin 3 ELISA Kit (AC3090) Quantitative inquiry ASET-1958 Human P311 ELISA Kit (AC3369) Quantitative inquiry ASET-1854 Human FGF1 ELISA Kit (AC3265) Quantitative inquiry ASET-1682 Human Somatostatin ELISA Kit (AC3093) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket